Haleon (NYSE:HLN) Reaches New 1-Year High at $10.76

Haleon plc (NYSE:HLN - Get Free Report)'s stock price hit a new 52-week high during trading on Friday . The company traded as high as $10.76 and last traded at $10.75, with a volume of 759959 shares. The stock had previously closed at $10.59.

Analysts Set New Price Targets

HLN has been the subject of a number of recent research reports. Berenberg Bank initiated coverage on shares of Haleon in a research note on Tuesday, August 6th. They issued a "buy" rating for the company. Morgan Stanley boosted their price objective on shares of Haleon from $9.90 to $10.95 and gave the stock an "overweight" rating in a research note on Friday, September 20th. Finally, The Goldman Sachs Group downgraded shares of Haleon from a "buy" rating to a "neutral" rating in a research note on Tuesday, August 6th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Haleon currently has an average rating of "Moderate Buy" and an average price target of $10.95.

Haleon Stock Performance

The business has a 50-day moving average price of $9.94 and a 200-day moving average price of $8.94. The firm has a market capitalization of $48.67 billion, a price-to-earnings ratio of 35.58, a P/E/G ratio of 3.12 and a beta of 0.26. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN - Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by ($0.01). The business had revenue of $3.50 billion for the quarter, compared to analyst estimates of $3.55 billion. Haleon had a return on equity of 13.15% and a net margin of 9.71%. During the same period in the previous year, the company posted $0.08 earnings per share. As a group, sell-side analysts forecast that Haleon plc will post 0.47 earnings per share for the current year.

Haleon Cuts Dividend

The company also recently announced a semi-annual dividend, which was paid on Thursday, September 19th. Investors of record on Friday, August 16th were given a $0.0514 dividend. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend was Friday, August 16th. Haleon's payout ratio is 36.67%.

Hedge Funds Weigh In On Haleon

Several hedge funds have recently made changes to their positions in HLN. Cultivar Capital Inc. acquired a new position in shares of Haleon in the 2nd quarter valued at $40,000. Allspring Global Investments Holdings LLC acquired a new position in shares of Haleon in the 1st quarter valued at $43,000. GAMMA Investing LLC increased its position in shares of Haleon by 151.3% in the 1st quarter. GAMMA Investing LLC now owns 6,106 shares of the company's stock valued at $52,000 after acquiring an additional 3,676 shares during the period. Pinnacle Bancorp Inc. increased its position in shares of Haleon by 29.8% in the 1st quarter. Pinnacle Bancorp Inc. now owns 6,188 shares of the company's stock valued at $53,000 after acquiring an additional 1,421 shares during the period. Finally, Hexagon Capital Partners LLC increased its position in shares of Haleon by 66.6% in the 2nd quarter. Hexagon Capital Partners LLC now owns 6,695 shares of the company's stock valued at $55,000 after acquiring an additional 2,677 shares during the period. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.